5news.U.S. news, all in one place

BREAKING

› The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Composting is an easy way to reduce food waste. Here's how to do it › We stopped using aluminum foil for cooking and you should too. Here's what to use instead › The beloved Dyson Supersonic hair dryer is at its lowest price ever › Everything you need to know about Way Day 2023, Wayfair's biggest sale of the year › The 10 best Amazon deals to shop this week › The 2024 presidential alternative many voters will want › Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell › Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials › The 7 best high-yield savings accounts of April 2023 › Taxes are due tomorrow. Here's how to file for an extension › Composting is an easy way to reduce food waste. Here's how to do it › We stopped using aluminum foil for cooking and you should too. Here's what to use instead › The beloved Dyson Supersonic hair dryer is at its lowest price ever › Everything you need to know about Way Day 2023, Wayfair's biggest sale of the year › The 10 best Amazon deals to shop this week › The 2024 presidential alternative many voters will want › Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell › Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials

Business

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time

Forbes · August 26, 2026 at 11:53 AM

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time

Rasonque joins a short list of treatment options for one of the country’s deadliest types of cancer.

Read the full article on Forbes ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.forbes.com — the content belongs to Forbes.

This story in other outlets

FDA approves ‘landmark’ pancreatic cancer drug that extends patients’ lives

The Washington Post · 39 min ago

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

The New York Times · 1 h ago

More from Forbes

NHL Sets Sights On TV Market Expansion Ahead Of New Rights Deal

Forbes · 15 min ago

Senate Races To Watch: Republican Hinson Leads In Iowa

Forbes · 16 min ago

Expert Witness Asked ChatGPT To Show 0% Fault—The Wrong Way For Experts To Use AI

Forbes · 19 min ago

Olivia Rodrigo’s Chart Comeback Involves Several Of Her Biggest Singles

Forbes · 29 min ago

More in Business

Mark Walter's TWG Global says there's 'no fraud' amid probe of insurers' disclosures

CNBC · 6 min ago

Does a 2% beneficiary inherit 100% if the 98% beneficiary dies in a car accident? Asking for a friend.

MarketWatch · 14 min ago

NHL Sets Sights On TV Market Expansion Ahead Of New Rights Deal

Forbes · 15 min ago

Why we need ‘Human Reserved’ jobs, says Bill Gates—and how we can combat the worst of the AI upheaval

CNBC · 15 min ago

Senate Races To Watch: Republican Hinson Leads In Iowa

Forbes · 16 min ago

S&P 500 falls slightly after PCE report shows sticky inflation; Nvidia earnings on deck: Live updates

CNBC · 17 min ago